Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Orsolya Polgar

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|December 13, 2002
ABC transporters and inhibitors: new targets, new agentsGregory D Leonard, Orsolya Polgar, Susan E Bates
Expert Opinion on Drug Metabolism & Toxicology|March 29, 2008
ABCG2: structure, function and role in drug responseOrsolya Polgar, Robert W Robey, Susan E Bates
Cancer Biology & Therapy|February 3, 2005
ABCG2-mediated transport of photosensitizers: potential impact on photodynamic therapyRobert W Robey, Kenneth Steadman, Orsolya Polgar, et al.
Research in Veterinary Science|July 1, 2006
The livestock photosensitizer, phytoporphyrin (phylloerythrin), is a substrate of the ATP-binding cassette transporter ABCG2Robert W Robey, Patricia A Fetsch, Orsolya Polgar, et al.
Cancer Metastasis Reviews|February 27, 2007
ABCG2: determining its relevance in clinical drug resistanceRobert W Robey, Orsolya Polgar, John Deeken, et al.
Molecular Cancer Research : MCR|February 1, 2008
Histone modifications at the ABCG2 promoter following treatment with histone deacetylase inhibitor mirror those in multidrug-resistant cellsKenneth K W To, Orsolya Polgar, Lyn M Huff, et al.
Journal of Molecular Graphics & Modelling|October 10, 2006
Towards understanding the mechanism of action of the multidrug resistance-linked half-ABC transporter ABCG2: a molecular modeling studyYong-Fu Li, Orsolya Polgar, Masaki Okada, et al.
Cancer Research|February 20, 2004
Pheophorbide a is a specific probe for ABCG2 function and inhibitionRobert W Robey, Kenneth Steadman, Orsolya Polgar, et al.
Advanced Drug Delivery Reviews|January 13, 2009
ABCG2: a perspectiveRobert W Robey, Kenneth K K To, Orsolya Polgar, et al.
Molecular Pharmacology|November 7, 2007
Reduced expression of DNA topoisomerase I in SF295 human glioblastoma cells selected for resistance to homocamptothecin and diflomotecanZhiyong Liao, Robert W Robey, Josée Guirouilh-Barbat, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Current Opinion in Investigational Drugs (London, England : 2000)|December 13, 2002
ABC transporters and inhibitors: new targets, new agentsGregory D Leonard, Orsolya Polgar, Susan E Bates
Expert Opinion on Drug Metabolism & Toxicology|March 29, 2008
ABCG2: structure, function and role in drug responseOrsolya Polgar, Robert W Robey, Susan E Bates
Cancer Biology & Therapy|February 3, 2005
ABCG2-mediated transport of photosensitizers: potential impact on photodynamic therapyRobert W Robey, Kenneth Steadman, Orsolya Polgar, et al.
Research in Veterinary Science|July 1, 2006
The livestock photosensitizer, phytoporphyrin (phylloerythrin), is a substrate of the ATP-binding cassette transporter ABCG2Robert W Robey, Patricia A Fetsch, Orsolya Polgar, et al.
Cancer Metastasis Reviews|February 27, 2007
ABCG2: determining its relevance in clinical drug resistanceRobert W Robey, Orsolya Polgar, John Deeken, et al.
Molecular Cancer Research : MCR|February 1, 2008
Histone modifications at the ABCG2 promoter following treatment with histone deacetylase inhibitor mirror those in multidrug-resistant cellsKenneth K W To, Orsolya Polgar, Lyn M Huff, et al.
Journal of Molecular Graphics & Modelling|October 10, 2006
Towards understanding the mechanism of action of the multidrug resistance-linked half-ABC transporter ABCG2: a molecular modeling studyYong-Fu Li, Orsolya Polgar, Masaki Okada, et al.
Cancer Research|February 20, 2004
Pheophorbide a is a specific probe for ABCG2 function and inhibitionRobert W Robey, Kenneth Steadman, Orsolya Polgar, et al.
Advanced Drug Delivery Reviews|January 13, 2009
ABCG2: a perspectiveRobert W Robey, Kenneth K K To, Orsolya Polgar, et al.
Molecular Pharmacology|November 7, 2007
Reduced expression of DNA topoisomerase I in SF295 human glioblastoma cells selected for resistance to homocamptothecin and diflomotecanZhiyong Liao, Robert W Robey, Josée Guirouilh-Barbat, et al.
Pageof 2